Gujarat Terce Laboratories Limited (BOM:524314)
India
· Delayed Price · Currency is INR 37.00
-1.26 (-3.29%)
At close: Apr 28, 2026
BOM:524314 Revenue
Gujarat Terce Laboratories had revenue of 122.94M INR in the quarter ending December 31, 2025, with 3.40% growth. This brings the company's revenue in the last twelve months to 483.98M, down -1.52% year-over-year. In the fiscal year ending March 31, 2025, Gujarat Terce Laboratories had annual revenue of 501.95M with 4.63% growth.
Revenue (ttm)
483.98M
Revenue Growth
-1.52%
P/S Ratio
0.60
Revenue / Employee
1.98M
Employees
244
Market Cap
288.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 501.95M | 22.21M | 4.63% |
| Mar 31, 2024 | 479.75M | 11.92M | 2.55% |
| Mar 31, 2023 | 467.83M | 66.49M | 16.57% |
| Mar 31, 2022 | 401.34M | 149.56M | 59.40% |
| Mar 31, 2021 | 251.78M | -123.66M | -32.94% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JFL Life Sciences | 744.78M |
| Rekvina Laboratories | 5.42M |
| Deccan Health Care | 816.77M |
| Murae Organisor | 8.59B |
| Walpar Nutritions | 757.46M |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Hamps Bio | 71.20M |
| Panjon | 493.34M |